Diabetes mellitus and vascular risk: continuing the quest for the elusive keystone

Abstract

References

1. Nathanson MH. Coronary disease in 100 autopsied diabetics. Am J Med 1932;183:495–502.

2. Joslin EP. Arteriosclerosis and diabetes. Ann Clin Med 1927;5:1061.

3. Gu K , Cowie CC , Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA 1999;281:1291–7.

4. Fox CS , Coady S , Sorlie PD et al. Trends in cardiovascular complications of diabetes. JAMA 2004;292:2495–9.

5. McKinlay J , Marceau L. US public health and the 21st century: diabetes mellitus. Lancet 2000;356:757–61.

6. Bhatt DL , Marso SP , Lincoff AM , Wolski KE , Ellis SG , Topol EJ. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 2000;35:922–8.

7. Roffi M , Chew DP , Mukherjee D et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. Circulation 2001;104:2767–71.

8. Sabatine MS , Braunwald E.

Will diabetes save the platelet blockers?

Circulation 2001;104:2759–61.